Regulation of NF-B activity by competition between RelA acetylation and ubiquitination

Oncogene

Volumn 31, Issue 5, 2012, Pages 611-623

  Li, H ^a   Wittwer, T ^b   Weber, A ^c   Schneider, H ^d   Moreno, R ^b   Maine, G N ^e   Kracht, M ^c   Schmitz, M L ^b   Burstein, E ^a,f  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e WILLIAM BEAUMONT HOSPITAL   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

acetylation; NF B; p65; RelA; transcription; ubiquitination

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; POLYUBIQUITIN; TRANSCRIPTION FACTOR RELA; ICAM1 PROTEIN, MOUSE; INTERCELLULAR ADHESION MOLECULE 1; RELA PROTEIN, MOUSE; UBIQUITIN;

ACETYLATION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REACTION ANALYSIS; SEQUENCE ANALYSIS; UBIQUITINATION; ANIMAL; BINDING SITE; CELL CULTURE; CELL STRAIN HEK293; CYTOLOGY; DNA MICROARRAY; FIBROBLAST; GENE EXPRESSION PROFILING; GENETICS; IMMUNOBLOTTING; METABOLISM; MOUSE MUTANT; MUTATION; PROMOTER REGION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ACETYLATION; ANIMALS; BINDING SITES; CELL LINE, TUMOR; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; INTERCELLULAR ADHESION MOLECULE-1; LYSINE; MICE; MICE, KNOCKOUT; MUTATION; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR RELA; UBIQUITIN; UBIQUITINATION;

EID: 84856533695     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.253     Document Type: Article

References (40)

1. Baeuerle PA, Baltimore D. (1988). IkB: a specific inhibitor of the NFkB transcription factor. Science 242: 540-546. (Pubitemid 18263193)
2. Bassères DS, Baldwin AS. (2006). Nuclear factor-kB and inhibitor of kB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817-6830. (Pubitemid 44657854)
3. Buerki C, Rothgiesser KM, Valovka T, Owen HR, Rehrauer H, Fey M et al. (2008). Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65. Nucleic Acids Res 36: 1665-1680. (Pubitemid 351426117)
4. Burstein E, Ganesh L, Dick RD, van De Sluis B, Wilkinson JC, Klomp LW et al. (2004). A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J 23: 244-254. (Pubitemid 38165764)
5. Burstein E, Hoberg JE, Wilkinson AS, Rumble JM, Csomos RA, Komarck CM et al. (2005). COMMD proteins: a novel family of structural and functional homologs of MURR1. J Biol Chem 280: 22222-22232. (Pubitemid 40827879)
6. Chen FE, Huang DB, Chen YQ, Ghosh G. (1998). Crystal structure of p50/p65 heterodimer of transcription factor NF-kB bound to DNA. Nature 391: 410-413.
7. Chen L, Fischle W, Verdin E, Greene WC. (2001). Duration of nuclear NF-kB action regulated by reversible acetylation. Science 293: 1653-1657. (Pubitemid 32807844)
8. Chen LF, Mu Y, Greene WC. (2002). Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kB. EMBO J 21: 6539-6548. (Pubitemid 35448431)
9. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D et al. (1995). Signal-induced site-specific phosphorylation targets IkBa to the ubiquitin-proteasome pathway. Genes Dev 9: 1586-1597.
10. Ea CK, Baltimore D. (2009). Regulation of NF-kB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA 106: 18972-18977.
11. Fan Y, Mao R, Zhao Y, Yu Y, Sun W, Song P et al. (2009). Tumor necrosis factor-a induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kB activation. J Biol Chem 284: 29290-29297.
12. Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, Schmitz ML. (2009). Phosphorylation of NF-kB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep 10: 381-386.
13. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. (1997). CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94: 2927-2932. (Pubitemid 27157241)
14. Hayden MS, Ghosh S. (2008). Shared principles in NF-kB signaling. Cell 132: 344-362.
15. Henkel T, Machleidt T, Alkalay I, Krö nke M, Ben-Neriah Y, Baeuerle PA. (1993). Rapid proteolysis of IkB-a is necessary for activation of transcription factor NF-kB. Nature 365: 182-185. (Pubitemid 23282067)
16. Hoffmann A, Natoli G, Ghosh G. (2006). Transcriptional regulation via the NF-kB signaling module. Oncogene 25: 6706-6716. (Pubitemid 44657847)
17. KarinM, Greten FR. (2005). NF-kB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
18. Karin M. (2006). Nuclear factor-kB in cancer development and progression. Nature 441: 431-436. (Pubitemid 44050137)
19. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C et al. (2003). Post-activation turn-off of NF-kB-dependent transcription is regulated by acetylation of p65. J Biol Chem 278: 2758-2766. (Pubitemid 36801357)
20. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M. (2005). IKKa limits macrophage NF-kB activation and contributes to the resolution of inflammation. Nature 434: 1138-1143. (Pubitemid 40663493)
21. Li M, Luo J, Brooks CL, Gu W. (2002). Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611. (Pubitemid 36042220)
22. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872. (Pubitemid 34118370)
23. Maine GN, Gluck N, Zaidi IW, Burstein E. (2009). Bimolecular affinity purification (BAP): tandem affinity purification using two protein baits. Cold Spring Harb Protoc (10.1101/pdb.prot5318).
24. Maine GN, Li H, Zaidi IW, Basrur V, Elenitoba-Johnson KS, Burstein E. (2010). A bimolecular affinity purification method under denaturing conditions for rapid isolation of a ubiquitinated protein for mass spectrometry analysis. Nat Protoc 5: 1447-1459.
25. Maine GN, Mao X, Komarck CM, Burstein E. (2007). COMMD1 promotes the ubiquitination of NF-kB subunits through a Cullincontaining ubiquitin ligase. EMBO J 26: 436-447. (Pubitemid 46160944)
26. Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW et al. (2009). GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kB/RelA. Genes Dev 23: 849-861.
27. Moreno R, Sobotzik JM, Schultz C, Schmitz ML. (2010). Specification of the NF-kB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKe. Nucleic Acids Res 38: 6029-6044.
28. Natoli G, Chiocca S. (2008). Nuclear ubiquitin ligases, NF-kB degradation, and the control of inflammation. Sci Signal 1: pe1.
29. Rothgiesser KM, Fey M, Hottiger MO. (2010). Acetylation of p65 at lysine 314 is important for late NF-kB-dependent gene expression. BMC Genomics 11: 22.
30. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G et al. (2003). Regulation of NF-kB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12: 1413-1426. (Pubitemid 38037011)
31. Saccani S, Marazzi I, Beg AA, Natoli G. (2004). Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kB response. J Exp Med 200: 107-113. (Pubitemid 38924733)
32. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. (1999). IkB kinases phosphorylate NF-kB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-30356.
33. Silverman N, Maniatis T. (2001). NF-kB signaling pathways in mammalian and insect innate immunity. Genes Dev 15: 2321-2342. (Pubitemid 32899738)
34. Tanaka T, Grusby MJ, Kaisho T. (2007). PDLIM2-mediated termination of transcription factor NF-kB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8: 584-591. (Pubitemid 46785122)
35. Wright CW, Duckett CS. (2009). The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kB-dependent transcription. Science 323: 251-255.
36. Xu M, Skaug B, Zeng W, Chen ZJ. (2009). A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFa and IL-1b. Mol Cell 36: 302-314.
37. Yang XD, Huang B, Li M, Lamb A, Kelleher NL, Chen LF. (2009). Negative regulation of NF-kB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 28: 1055-1066.
38. Yang XD, Tajkhorshid E, Chen LF. (2010). Functional interplay between acetylation and methylation of the RelA subunit of NF-kB. Mol Cell Biol 30: 2170-2180.
39. Zhong H, May MJ, Jimi E, Ghosh S. (2002). The phosphorylation status of nuclear NF-kB determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636. (Pubitemid 34273792)
40. Zhong H, Voll RE, Ghosh S. (1998). Phosphorylation of NF-kB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671. (Pubitemid 128379244)